AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Aug 27, 2020
29821_dirs_2020-08-27_2cd366cf-1d4b-42e5-b4d0-25b50f34b191.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-08-26
Reporting Person: Eddy Jodi Euerle (SVP, Chief Info & Digital Off.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-26 | Common Stock | S | 7750.0000 | $38.9844 | Disposed | 10299.0000 | Direct |
Footnotes
F1: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $38.1812 to $39.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.